BriaCell Therapeutics Corp.
BCTX· Nasdaq
BriaCell Therapeutics Corp.
- Last sale
- Oct 1, 2026 · -3.05%
- Market cap
- $35.93M
- 8.7M shares
- Filings
- 323
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-07-31 | $21,270,678 | reported | |
| FY 2024 | 2024-07-31 | $27,177,807 | reported | |
| FY 2023 | 2023-07-31 | $15,336,638 | reported | |
| FY 2022 | 2022-07-31 | $8,021,489 | reported | |
| FY 2021 | 2021-07-31 | $2,020,899 revised | reported | |
| FY 2020 | 2020-07-31 | $2,425,838 | reported |
BriaCell Therapeutics Corp. · CIK 1610820 · Engraved from SEC EDGAR
